222 related articles for article (PubMed ID: 15061849)
1. Guidelines for the management of squamous cell carcinoma in organ transplant recipients.
Stasko T; Brown MD; Carucci JA; Euvrard S; Johnson TM; Sengelmann RD; Stockfleth E; Tope WD; ;
Dermatol Surg; 2004 Apr; 30(4 Pt 2):642-50. PubMed ID: 15061849
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
3. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
4. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site.
Lindelöf B; Dal H; Wolk K; Malmborg N
Arch Dermatol; 2005 Apr; 141(4):447-51. PubMed ID: 15837862
[TBL] [Abstract][Full Text] [Related]
6. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
7. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients].
Lapointe AK; Hofbauer G; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Pascual M; Pelloni F; Serra A; Laffitte E
Rev Med Suisse; 2010 Apr; 6(246):854-9. PubMed ID: 20455382
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations.
Martinez JC; Otley CC; Okuno SH; Foote RL; Kasperbauer JL
Dermatol Surg; 2004 Apr; 30(4 Pt 2):679-86. PubMed ID: 15061855
[TBL] [Abstract][Full Text] [Related]
9. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
Bangash HK; Colegio OR
Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma in organ transplant recipients: approach to management.
Carucci JA
Skin Therapy Lett; 2004 Apr; 9(4):5-7. PubMed ID: 15146264
[TBL] [Abstract][Full Text] [Related]
11. Organ transplantation and skin cancer: basic problems and new perspectives.
Hofbauer GF; Bouwes Bavinck JN; Euvrard S
Exp Dermatol; 2010 Jun; 19(6):473-82. PubMed ID: 20482618
[TBL] [Abstract][Full Text] [Related]
12. Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR).
Reichrath J
J Photochem Photobiol B; 2010 Nov; 101(2):150-9. PubMed ID: 20434355
[TBL] [Abstract][Full Text] [Related]
13. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.
Mühleisen B; Petrov I; Gächter T; Kurrer M; Schärer L; Dummer R; French LE; Hofbauer GF
Histopathology; 2009 Jul; 55(1):67-76. PubMed ID: 19614769
[TBL] [Abstract][Full Text] [Related]
14. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
Leblanc KG; Hughes MP; Sheehan DJ
Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
[TBL] [Abstract][Full Text] [Related]
15. Pronounced allelic imbalance at D9S162 in skin squamous cell carcinoma of organ transplant recipients.
Mühleisen B; Petrov I; Frigerio S; Dziunycz P; French LE; Hofbauer GF
Arch Dermatol; 2012 Jun; 148(6):697-703. PubMed ID: 22508773
[TBL] [Abstract][Full Text] [Related]
16. Sun protection attitudes and behaviors of solid-organ transplant recipients.
Robinson JK; Rigel DS
Dermatol Surg; 2004 Apr; 30(4 Pt 2):610-5. PubMed ID: 15061844
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the head and neck region in solid organ transplant recipients.
Rabinovics N; Mizrachi A; Hadar T; Ad-El D; Feinmesser R; Guttman D; Shpitzer T; Bachar G
Head Neck; 2014 Feb; 36(2):181-6. PubMed ID: 23554129
[TBL] [Abstract][Full Text] [Related]
18. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs).
Reichrath J; Nürnberg B
Adv Exp Med Biol; 2008; 624():203-14. PubMed ID: 18348458
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):263-279. PubMed ID: 21763562
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Types of Genital Lesions in Organ Transplant Recipients.
Nadhan KS; Larijani M; Abbott J; Doyle AM; Linfante AW; Chung CL
JAMA Dermatol; 2018 Mar; 154(3):323-329. PubMed ID: 29387873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
